MENORA MIVTACHIM HOLDINGS LTD.MENORA MIVTACHIM HOLDINGS LTD.

Institutional investor · Portfolio as of Q1 2022

SEC EDGAR SourceSEC Filings

Top Holdings59 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

2.3M$712.4M10.3%$209.09+45.54%
13 qtrssince 2019-Q1
Decreased
0

APPLE INC

3.7M$652.9M9.4%$115.17+48.28%
13 qtrssince 2019-Q1
Unchanged
0

ALPHABET INC-CL A

205,120$570.5M8.3%$103.57+36.01%
13 qtrssince 2019-Q1
Increased
78

AMAZON.COM INC

123,825$403.7M5.8%$136.38+21.94%
13 qtrssince 2019-Q1
Decreased
0

MASTERCARD INC - A

918,838$328.4M4.7%$351.12+0.76%
5 qtrssince 2021-Q1
Decreased
0

APPLIED MATERIALS INC

2.2M$290.7M4.2%$130.42-2.60%
5 qtrssince 2021-Q1
Increased
70

META PLATFORMS INC-CLASS A

1M$224.1M3.2%$282.54-19.92%
8 qtrssince 2020-Q2
Increased
58

NVIDIA CORP

815,280$222.5M3.2%$17.43+58.59%
13 qtrssince 2019-Q1
Increased
56
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

23.3M$218.9M3.2%$9.35+0.35%
10 qtrssince 2019-Q4
Increased
57

DEERE AND CO

507,000$210.6M3.0%$290.25+35.96%
6 qtrssince 2020-Q4
Decreased
0

HOME DEPOT INC

635,292$190.2M2.8%$244.54+14.70%
13 qtrssince 2019-Q1
Increased
80
PLDPLD
REIT

PROLOGIS INC

1.1M$181.4M2.6%$87.52+67.17%
7 qtrssince 2020-Q3
Unchanged
0

THERMO FISHER SCIENTIFIC INC

294,695$174.1M2.5%$314.33+87.35%
13 qtrssince 2019-Q1
Unchanged
0

FREEPORT-MCMORAN INC

3.1M$155.5M2.2%$7.58+515.84%
9 qtrssince 2020-Q1
Decreased
0

ABBVIE INC

931,370$151M2.2%$89.08+54.90%
8 qtrssince 2020-Q2
Increased
64

HONEYWELL INTL INC

755,220$147M2.1%$154.23+10.92%
13 qtrssince 2019-Q1
Increased
59

ABBOTT LABORATORIES

1.2M$139.6M2.0%$97.58+10.87%
7 qtrssince 2020-Q3
Increased
52

OTIS WORLDWIDE CORP

1.8M$136.1M2.0%$57.67+23.53%
8 qtrssince 2020-Q2
Increased
55

MICRON TECHNOLOGY INC

1.7M$135.5M2.0%$64.25+20.51%
9 qtrssince 2020-Q1
Increased
55
SONYSONY
ADR

SONY CORP-SPONSORED ADR

1.3M$135.2M2.0%$11.71+76.07%
13 qtrssince 2019-Q1
Decreased
0
$6.9B
AUM
59
Positions
Q1 2022
Filing
Rating · 2.0
Quarterly Portfolio Change
+27%Q4'20$5.7B+7%Q1'21$6.1B+14%Q2'21$6.9B-1%Q3'21$6.8B+7%Q4'21$7.4B-6%Q1'22$6.9B
Activity profile
$ moved · Q1'22
New8%Increased41%Decreased44%Exited7%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.1 years
<1Q2%1-4Q14%1-2Y24%2Y+61%

MENORA MIVTACHIM HOLDINGS LTD. manages $6.9B across 59 positions as of Q1 2022. Top holdings: MSFT (10.3%), AAPL (9.4%), GOOGL (8.3%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q1 2022 Summary

Added 2 new positions, exited 2, increased 20, trimmed 18. Top move: HD (INCREASED, conviction 80). Portfolio: $6.9B across 59 positions.

Top holdings by portfolio weight

Total AUM$7B
MSFT10.30%
AAPL9.44%
GOOGL8.25%
AMZN5.84%
MA4.75%
AMAT4.20%
META3.24%
NVDA3.22%
TEVA3.17%
DE3.05%
Other2.75%

Portfolio allocation by GICS sector

Sectors11
Technology38.83%
Communication Services12.19%
Healthcare11.08%
Consumer Cyclical10.98%
Industrials8.82%
Financial Services4.78%
Basic Materials3.37%
Real Estate2.62%
Consumer Defensive2.61%
Utilities2.00%
Other2.71%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Communication Services, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record52
Conviction45
Concentration62
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
TEVATEVATEVA PHARMACEUTICAL-SP ADR
Q1 2025 Q2 2026+11.5M shares+$724.7M
5Q
KREKRESPDR SERIES TRUST
Q2 2025 Q2 2026+3.3M shares+$248M
4Q
QQQQQQINVESCO QQQ TRUST SERIES 1 CL USD INC
Q3 2025 Q2 2026+10,060 shares+$9.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used